(E,Z)-ethyl 2-cyano-3-(1-((2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)-tetrahydrofuran-2-yl)-2,4-dioxo-1,2,3,4-tetrahydropyrimidin-5-yl)acrylate

ID: ALA443308

Cas Number: 911843-45-3

PubChem CID: 44416395

Max Phase: Preclinical

Molecular Formula: C15H17N3O7

Molecular Weight: 351.32

Molecule Type: Small molecule

This compound is available for customization.

Associated Items:

Names and Identifiers

Canonical SMILES:  CCOC(=O)/C(C#N)=C/c1cn([C@H]2C[C@H](O)[C@@H](CO)O2)c(=O)[nH]c1=O

Standard InChI:  InChI=1S/C15H17N3O7/c1-2-24-14(22)8(5-16)3-9-6-18(15(23)17-13(9)21)12-4-10(20)11(7-19)25-12/h3,6,10-12,19-20H,2,4,7H2,1H3,(H,17,21,23)/b8-3+/t10-,11+,12+/m0/s1

Standard InChI Key:  MYQZREIBPFMKQP-OCTANDHXSA-N

Molfile:  

     RDKit          2D

 25 26  0  0  1  0  0  0  0  0999 V2000
   -0.6672  -23.3420    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -0.0814  -23.9233    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.7177  -23.7039    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.9271  -22.9071    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.3414  -22.3258    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.4577  -22.5412    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.2909  -24.7201    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    1.7262  -22.6877    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -2.1101  -23.0405    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -2.8018  -23.4929    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.5825  -24.2920    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.7570  -24.3295    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.4663  -23.5574    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.1033  -24.9358    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -3.5739  -23.1984    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.2137  -23.7240    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.5521  -21.5307    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.3459  -21.3157    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.5567  -20.5206    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.9291  -21.8957    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.5137  -22.4728    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    2.3511  -20.3049    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.9740  -19.9399    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    2.9346  -20.8847    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.7284  -20.6692    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  9 10  1  0
 10 11  1  0
 11 12  1  0
 12 13  1  0
 13  9  1  0
 13  1  1  1
 11 14  1  6
 10 15  1  1
 15 16  1  0
  5 17  1  0
  1  2  1  0
 17 18  2  0
  1  6  1  0
 18 19  1  0
  2  3  1  0
 18 20  1  0
  3  4  1  0
 20 21  3  0
  4  5  1  0
  5  6  2  0
 19 22  1  0
 19 23  2  0
  2  7  2  0
 22 24  1  0
  4  8  2  0
 24 25  1  0
M  END

Associated Targets(Human)

HFF (3142 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

Leishmania donovani (89745 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Vaccinia virus (4609 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Cowpox virus (428 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Human alphaherpesvirus 1 (11089 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Human alphaherpesvirus 2 (4932 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Human alphaherpesvirus 3 (4092 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
OPG101 Thymidine kinase (42 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 351.32Molecular Weight (Monoisotopic): 351.1066AlogP: -1.35#Rotatable Bonds: 5
Polar Surface Area: 154.64Molecular Species: NEUTRALHBA: 9HBD: 3
#RO5 Violations: HBA (Lipinski): 10HBD (Lipinski): 3#RO5 Violations (Lipinski):
CX Acidic pKa: 9.55CX Basic pKa: CX LogP: -1.00CX LogD: -1.01
Aromatic Rings: 1Heavy Atoms: 25QED Weighted: 0.33Np Likeness Score: 0.17

References

1. Torrence PF, Fan X, Zhang X, Loiseau PM..  (2006)  Structurally diverse 5-substituted pyrimidine nucleosides as inhibitors of Leishmania donovani promastigotes in vitro.,  16  (19): [PMID:16879965] [10.1016/j.bmcl.2006.07.042]
2. Prichard MN, Keith KA, Johnson MP, Harden EA, McBrayer A, Luo M, Qiu S, Chattopadhyay D, Fan X, Torrence PF, Kern ER..  (2007)  Selective phosphorylation of antiviral drugs by vaccinia virus thymidine kinase.,  51  (5): [PMID:17325220] [10.1128/aac.01447-06]

Source